{"url":"https://lda.senate.gov/api/v1/filings/d2915c9d-b382-469a-9ebf-01ac26ee098b/","filing_uuid":"d2915c9d-b382-469a-9ebf-01ac26ee098b","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d2915c9d-b382-469a-9ebf-01ac26ee098b/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Sophia Tiratto","dt_posted":"2024-10-21T12:48:57-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5331 16th street NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20011","registrant":{"id":401105372,"url":"https://lda.senate.gov/api/v1/registrants/401105372/","house_registrant_id":null,"name":"THE KPM GROUP DC LLC","description":"lobby firm","address_1":"5331 16th Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20011","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISA HESS","contact_telephone":"+1 434-933-2535","dt_updated":"2026-07-20T15:33:02.088040-04:00"},"client":{"id":57168,"url":"https://lda.senate.gov/api/v1/clients/57168/","client_id":57168,"name":"ASTRIA THERAPEUTICS, INC.","general_description":"Develop therapies for patients with HAE, rare, and niche allergic and immunologic diseases","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-09-27"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act of 2024 S.4905, Innovation in Pediatric Drugs Act H.R.4758/S.2372, Accelerating Kids Access to Care Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":121710,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"ROOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147780,"prefix":null,"prefix_display":null,"first_name":"PAULA","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}